Details for New Drug Application (NDA): 020438
✉ Email this page to a colleague
NDA 020438 describes VESANOID, which is a drug marketed by Cheplapharm and is included in one NDA. Additional details are available on the VESANOID profile page.
The generic ingredient in VESANOID is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
The generic ingredient in VESANOID is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Summary for 020438
| Tradename: | VESANOID |
| Applicant: | Cheplapharm |
| Ingredient: | tretinoin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020438
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Nov 22, 1995 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
